Lifetech CeraFlex™ Post-Market Surveillance Study

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

January 31, 2019

Study Completion Date

February 29, 2020

Conditions
Patent Foramen OvaleAtrial Septal DefectPatent Ductus Arteriosus
Interventions
DEVICE

CeraFlex

The Lifetech CeraFlex™ study is a triple-arm study.

Trial Locations (7)

Unknown

AP Hospital Europeen G Pompidou and Hospital Necker, Paris

Deutsches Herzzentrum Berlin, Berlin

Herzzentrum Leipzig GmbH, Leipzig

Deutsches Herzzentrum München, Munich

Our Lady's Children's Hospital Crumlin, Dublin

Policlinico San Donato S.P.A., Milan

Kinderspital Zürich, Zurich

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Lifetech Scientific (Shenzhen) Co., Ltd.

INDUSTRY